Sevoflurane is an inhaled anesthetic gas used to put patients to sleep during surgery and medical procedures. It helps keep patients unconscious and pain-free while doctors perform operations.[2] Ultane is currently approved and in use across 83 indications[4].[1]
Ultane is one of 1234 small molecule programs targeting Coronary Artery Disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2829 competitors in Breast Cancer
Ultane
Halaven
Tykerb
Adriamycin
Avastin
Nolvadex
Prolia
Gemzar
Blenoxane
Voltaren
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jun 7, 1995
ULTANE
NDA NDA020478
Sources
Details